# Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

> **NCT00146627** · PHASE3 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 280 (estimated)

## Conditions studied

- Trypanosomiasis, African

## Interventions

- **DRUG:** Eflornithine
- **DRUG:** Nifurtimox

## Key facts

- **NCT ID:** NCT00146627
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2016-09-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146627, "Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00146627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*